AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 297: L467-L474, 2009. First published July 2, 2009; doi:10.1152/ajplung.90553.2008
1040-0605/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/L467    most recent
90553.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Cagnina, R. E.
Right arrow Articles by Linden, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cagnina, R. E.
Right arrow Articles by Linden, J.

Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells

Rebecca E. Cagnina,1,2 Susan I. Ramos,1,3 Melissa A. Marshall,1,3 Guoquan Wang,4 C. Renea Frazier,4 and Joel Linden1,3

1Robert M. Berne Cardiovascular Research Center, Departments of 2Molecular Physiology and Biological Physics and 3Internal Medicine, University of Virginia, Charlottesville, Virginia; and 4PGxHealth, LLC, a Division of Clinical Data, Incorporated, Charlottesville, Virginia

Submitted 6 November 2008 ; accepted in final form 1 July 2009

The adenosine A2B receptor (A2BR) has a wide tissue distribution that includes fibroblasts and endothelial and epithelial cells. The recent generation of an A2BR–/– mouse constructed with a β-galactosidase (β-gal) reporter gene under control of the endogenous promoter has provided a valuable tool to quantify A2BR promoter activity (29). To determine the sites of expression of the A2B receptor in the mouse lung, histological and flow cytometric analysis of β-gal reporter gene expression in various lung cell populations was performed. The major site of A2BR promoter activity was found to be the type II alveolar epithelial cells (AECs), identified by coexpression of prosurfactant protein C, with relatively less expression in alveolar macrophages, bronchial epithelial cells, and cells of the vasculature. Highly purified type II AECs were prepared by fluorescence-activated sorting of enhanced green fluorescent protein (eGFP)-positive cells from transgenic mice expressing eGFP under control of the surfactant protein C promoter (21). The type II cells expressed 89-fold higher A2BR mRNA than pulmonary leukocytes, and the A2BR was shown to be functional, as treatment of purified type II AECs with the nonspecific adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine (NECA) induced an increase in intracellular cAMP greater that the β-adrenergic agonist isoproterenol that was inhibited completely following treatment by ATL-802, a novel, highly potent (Ki = 8.6 nM), and selective (>900 fold over other adenosine receptor subtypes) antagonist of the mouse A2BR.

lung; β-galactosidase; G protein-coupled receptor; cAMP



Address for reprint requests and other correspondence: J. Linden, CVRC - Univ. of Virginia, MR5 Rm 1214, Box 801394, Charlottesville, VA 22908 (e-mail: jlinden{at}virginia.edu)




This article has been cited by other articles:


Home page
PhysiologyHome page
T. Eckle, M. Koeppen, and H. K. Eltzschig
Role of Extracellular Adenosine in Acute Lung Injury
Physiology, October 1, 2009; 24(5): 298 - 306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.